Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
This study seeks to evaluate the safety and efficacy of Nelotanserin for the treatment of
Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) in subjects with dementia with Lewy
bodies (DLB) or Parkinson's disease dementia (PDD).